PA
SEDG icon

PharVision Advisers’s SolarEdge SEDG Stock Holding History

PharVision Advisers’s Portfolio SEDG Stock Details SEDG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,055
Closed -$483K – 971
2025
Q3 		$483K Buy
+13,055
New +$390K 0.27% 29
2025
Q1 		– Sell
-18,826
Closed -$256K – 487
2024
Q4 		$256K Buy
+18,826
New +$290K 0.22% 213

Other funds holding SEDG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ECP
Electron Capital Partners New York $2.55B AUM 87.77% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PharVision Advisers's SEDG Position: Q4 2025 in Review

PharVision Advisers sold out of SolarEdge (SEDG) in Q4 2025, closing a stake of 13,055 shares — an estimated $483K sold.

PharVision Advisers first reported a position in SEDG in Q4 2024 and held it in 2 quarters. The position peaked at $483K in Q3 2025. 304 funds tracked by Wall St. Rank hold SEDG as of Q4 2025.

  • PharVision Advisers reported no remaining SolarEdge position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 13,055 SolarEdge shares in Q4 2025, an estimated $483K.
  • PharVision Advisers first reported a position in SolarEdge in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's SolarEdge position peaked at $483K in Q3 2025.
  • 304 funds tracked by Wall St. Rank held SolarEdge as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.